Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*-Reference-Cited by-同舟云学术

Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*

Published:1995-07 Issue:1 Volume:58 Page:44-53
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Zhang Ruiwen,Yan Jieming,Shahinian Harout,Amin Girish,Lu Zhihong,Liu Tiepu,Saag Michael S.,Jiang Zhiwei,Temsamani Jamal,Martin R. Russell,Schechter Paul J.,Agrawal Sudhir,Diasio Robert B.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference32 articles.

1. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

2. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus.

3. Inhibition of human immunodeficiency virus replication by antisense oligodeoxynucleotides.

4. Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus.

5. Regulation of viral expression of human immunodeficiency virus in vitro by an antisense phosphorothioate oligodeoxynucleotide against rev (art/trs) in chronically infected cells.

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations for Creating the Next Generation of RNA Therapeutics: Oligonucleotide Chemistry and Innate Immune Responses to Nucleic Acids;Nucleic Acid Therapeutics;2024-04-01

2. The Evolution of Antisense Oligonucleotide Chemistry—A Personal Journey;Biomedicines;2021-05-03

3. Antisense molecules: A new class of drugs;Journal of Allergy and Clinical Immunology;2016-05

4. Separation and identification of phosphorothioate oligonucleotides by HILIC-ESIMS;Analytical Methods;2013

5. Pharmacokinetic Allometric Scaling of Oligonucleotides;Nucleic Acid Therapeutics;2011-10